Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lesley Fallowfield

Showing results (91-100 of 111) with videos related to

Pageof 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2016
Endocrine Therapy for Hormone Receptor-Positive Metastatic Breast Cancer: American Society of Clinical Oncology GuidelineHope S Rugo, R Bryan Rumble, Erin Macrae, et al.
Journal of the National Cancer Institute|May 4, 2006
Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC TrialRobert E Mansel, Lesley Fallowfield, Mark Kissin, et al.
Cancers|March 6, 2021
Performance Characteristics of the Ultrasound Strategy during Incidence Screening in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)Jatinderpal Kalsi, Aleksandra Gentry-Maharaj, Andy Ryan, et al.
Cancer|September 7, 2012
Pain outcomes in patients with advanced breast cancer and bone metastases: results from a randomized, double-blind study of denosumab and zoledronic acidCharles S Cleeland, Jean-Jacques Body, Alison Stopeck, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2015
Addressing overtreatment of screen detected DCIS; the LORIS trialAdele Francis, Jeremy Thomas, Lesley Fallowfield, et al.
The Lancet. Oncology|September 1, 2023
Tumour stage, treatment, and survival of women with high-grade serous tubo-ovarian cancer in UKCTOCS: an exploratory analysis of a randomised controlled trialUsha Menon, Aleksandra Gentry-Maharaj, Matthew Burnell, et al.
NPJ Breast Cancer|July 9, 2026
Routine germline genetic testing in 3552 unselected NHS breast cancer patients: evidence informing testing criteria and implementation of a 'BRCA-DIRECT' mainstreaming pathwayBethany Torr, Lea Mansour, Caitlin T Fierheller, et al.
Journal of Medical Genetics|March 13, 2025
Uptake, utility and resource requirements of a genetic counselling telephone helpline within the BRCA-DIRECT digital pathway for mainstreamed BRCA testing in patients with breast cancerBethany Torr, Grace Kavanaugh, Monica Hamill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2017
Long-Term Follow-Up of the Intergroup Exemestane StudyJames P Morden, Isabel Alvarez, Gianfilippo Bertelli, et al.
Trials|March 3, 2011
Impact on mortality and cancer incidence rates of using random invitation from population registers for recruitment to trialsMatthew Burnell, Aleksandra Gentry-Maharaj, Andy Ryan, et al.
Pageof 12

Showing results (91-100 of 111) with videos related to

Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2016
Endocrine Therapy for Hormone Receptor-Positive Metastatic Breast Cancer: American Society of Clinical Oncology GuidelineHope S Rugo, R Bryan Rumble, Erin Macrae, et al.
Journal of the National Cancer Institute|May 4, 2006
Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC TrialRobert E Mansel, Lesley Fallowfield, Mark Kissin, et al.
Cancers|March 6, 2021
Performance Characteristics of the Ultrasound Strategy during Incidence Screening in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)Jatinderpal Kalsi, Aleksandra Gentry-Maharaj, Andy Ryan, et al.
Cancer|September 7, 2012
Pain outcomes in patients with advanced breast cancer and bone metastases: results from a randomized, double-blind study of denosumab and zoledronic acidCharles S Cleeland, Jean-Jacques Body, Alison Stopeck, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2015
Addressing overtreatment of screen detected DCIS; the LORIS trialAdele Francis, Jeremy Thomas, Lesley Fallowfield, et al.
The Lancet. Oncology|September 1, 2023
Tumour stage, treatment, and survival of women with high-grade serous tubo-ovarian cancer in UKCTOCS: an exploratory analysis of a randomised controlled trialUsha Menon, Aleksandra Gentry-Maharaj, Matthew Burnell, et al.
NPJ Breast Cancer|July 9, 2026
Routine germline genetic testing in 3552 unselected NHS breast cancer patients: evidence informing testing criteria and implementation of a 'BRCA-DIRECT' mainstreaming pathwayBethany Torr, Lea Mansour, Caitlin T Fierheller, et al.
Journal of Medical Genetics|March 13, 2025
Uptake, utility and resource requirements of a genetic counselling telephone helpline within the BRCA-DIRECT digital pathway for mainstreamed BRCA testing in patients with breast cancerBethany Torr, Grace Kavanaugh, Monica Hamill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2017
Long-Term Follow-Up of the Intergroup Exemestane StudyJames P Morden, Isabel Alvarez, Gianfilippo Bertelli, et al.
Trials|March 3, 2011
Impact on mortality and cancer incidence rates of using random invitation from population registers for recruitment to trialsMatthew Burnell, Aleksandra Gentry-Maharaj, Andy Ryan, et al.
Pageof 12